GESIURIS HEALTHCARE & INNOVATION FI
•CLASE A
Cartera Renta Variable
| 2024-Q2 | ||||
|---|---|---|---|---|
1 | ELI LILLY AND CO | 929.635 € | 6.27% | 60.04% |
2 | UNITEDHEALTH GROUP INC | 846.152 € | 5.71% | 18.28% |
3 | NOVO NORDISK AS CLASS B | 763.238 € | 5.15% | 87.35% |
4 | MERCK & CO INC | 730.343 € | 4.93% | 30.89% |
5 | AMGEN INC | 729.138 € | 4.92% | 36.32% |
6 | JOHNSON & JOHNSON | 654.875 € | 4.42% | 3.91% |
7 | ROCHE HOLDING AG | 645.232 € | 4.35% | 20.12% |
8 | NOVARTIS AG REGISTERED SHARES | 615.271 € | 4.15% | 9.28% |
9 | ASTRAZENECA PLC | 612.224 € | 4.13% | 56.47% |
10 | REGENERON PHARMACEUTICALS INC | 588.647 € | 3.97% | 23.31% |
11 | GILEAD SCIENCES INC | 492.496 € | 3.32% | 0.17% |
12 | THERMO FISHER SCIENTIFIC INC | 412.956 € | 2.79% | 7.35% |
13 | GSK PLC | 389.750 € | 2.63% | 94.16% |
14 | IDEXX LABORATORIES INC | 363.820 € | 2.45% | 9.55% |
15 | SANOFI SA | 359.760 € | 2.43% | 11.33% |
16 | PFIZER INC | 352.590 € | 2.38% | 0.14% |
17 | BRISTOL-MYERS SQUIBB CO | 348.894 € | 2.35% | 25.1% |
18 | ABBVIE INC | 341.023 € | 2.3% | 247.03% |
19 | INTUITIVE SURGICAL INC | 332.195 € | 2.24% | 8.7% |
20 | ALCON INC | 316.601 € | 2.14% | 17.86% |
21 | MEDTRONIC PLC | 315.927 € | 2.13% | 1.55% |
22 | STRAUMANN HOLDING AG | 312.108 € | 2.1% | 20.84% |
23 | ABBOTT LABORATORIES | 271.584 € | 1.83% | 2.72% |
24 | VEEVA SYSTEMS INC CLASS A | 239.162 € | 1.61% | Nueva |
25 | ZOETIS INC CLASS A | 203.896 € | 1.38% | 9.49% |
26 | ELEVANCE HEALTH INC | 202.319 € | 1.36% | Nueva |
27 | IQVIA HOLDINGS INC | 187.499 € | 1.26% | Nueva |
28 | DEMANT AS | 185.917 € | 1.25% | 14.19% |
29 | SONOVA HOLDING AG | 172.988 € | 1.17% | 6.43% |
30 | AMPLIFON SPA AZ NOM POST FRAZIONAMENTO | 166.200 € | 1.12% | 17.85% |
31 | ALIGN TECHNOLOGY INC | 135.217 € | 0.91% | 50.48% |
32 | DANAHER CORP | 118.943 € | 0.8% | 89.19% |
33 | HALOZYME THERAPEUTICS INC | 117.300 € | 0.79% | Nueva |
34 | SANDOZ GROUP AG REGISTERED SHARES | 94.628 € | 0.64% | 189.92% |
35 | KONINKLIJKE PHILIPS NV | 89.925 € | 0.61% | 36.21% |
36 | VIATRIS INC | 84.341 € | 0.57% | Nueva |
| 2024-Q4 | ||||
|---|---|---|---|---|
1 | UNITEDHEALTH GROUP INC | 811.096 € | 5.18% | 4.14% |
2 | ELI LILLY AND CO | 768.048 € | 4.91% | 17.38% |
3 | ROCHE HOLDING AG | 745.112 € | 4.76% | 15.48% |
4 | NOVARTIS AG REGISTERED SHARES | 735.430 € | 4.7% | 19.53% |
5 | ABBVIE INC | 686.564 € | 4.39% | 101.32% |
6 | MERCK & CO INC | 674.538 € | 4.31% | 7.64% |
7 | JOHNSON & JOHNSON | 670.507 € | 4.28% | 2.39% |
8 | BRISTOL-MYERS SQUIBB CO | 655.578 € | 4.19% | 87.9% |
9 | AMGEN INC | 654.558 € | 4.18% | 10.23% |
10 | PFIZER INC | 627.823 € | 4.01% | 78.06% |
11 | ASTRAZENECA PLC | 611.608 € | 3.91% | 0.1% |
12 | NOVO NORDISK AS CLASS B | 590.100 € | 3.77% | 22.68% |
13 | GSK PLC | 529.361 € | 3.38% | 35.82% |
14 | SANOFI SA | 520.257 € | 3.32% | 44.61% |
15 | GILEAD SCIENCES INC | 414.875 € | 2.65% | 15.76% |
16 | MEDTRONIC PLC | 408.929 € | 2.61% | 29.44% |
17 | THERMO FISHER SCIENTIFIC INC | 401.994 € | 2.57% | 2.65% |
18 | REGENERON PHARMACEUTICALS INC | 378.423 € | 2.42% | 35.71% |
19 | ALIGN TECHNOLOGY INC | 362.521 € | 2.32% | 168.1% |
20 | IDEXX LABORATORIES INC | 347.429 € | 2.22% | 4.51% |
21 | STRAUMANN HOLDING AG | 328.322 € | 2.1% | 5.19% |
22 | ABBOTT LABORATORIES | 305.909 € | 1.95% | 12.64% |
23 | VEEVA SYSTEMS INC CLASS A | 304.622 € | 1.95% | 27.37% |
24 | IQVIA HOLDINGS INC | 284.715 € | 1.82% | 51.85% |
25 | ALCON INC | 278.282 € | 1.78% | 12.1% |
26 | AMPLIFON SPA AZ NOM POST FRAZIONAMENTO | 263.410 € | 1.68% | 58.49% |
27 | ZOETIS INC CLASS A | 226.620 € | 1.45% | 11.14% |
28 | DEMANT AS | 223.196 € | 1.43% | 20.05% |
29 | SONOVA HOLDING AG | 220.755 € | 1.41% | 27.61% |
30 | VIATRIS INC | 220.067 € | 1.41% | 160.93% |
31 | ELEVANCE HEALTH INC | 199.540 € | 1.27% | 1.37% |
32 | SANDOZ GROUP AG REGISTERED SHARES | 183.961 € | 1.18% | 94.4% |
33 | INTUITIVE SURGICAL INC | 156.291 € | 1% | 52.95% |
34 | ALEXANDRIA REAL ESTATE EQUITIES INC | 150.758 € | 0.96% | Nueva |
35 | HALOZYME THERAPEUTICS INC | 147.776 € | 0.94% | 25.98% |
36 | GRIFOLS SA ORDINARY SHARES - CLASS A | 137.220 € | 0.88% | Nueva |
37 | VERTEX PHARMACEUTICALS INC | 116.691 € | 0.75% | Nueva |
38 | DANAHER CORP | 113.079 € | 0.72% | 4.93% |
39 | KONINKLIJKE PHILIPS NV | 0 € | Vendida | |